Differential Effect of Weight Loss on Insulin Resistance in Surgically Treated Obese Patients

Abstract

Purpose: To compare the effects of equivalent weight loss induced by two bariatric surgical techniques on insulin action in severely obese patients. Methods: Eighteen nondiabetic patients with severe obesity (mean [± SD] body mass index: 53.5 ± 9 kg/m²) and 20 sex- and age-matched lean subjects (body mass index: 23.8 ± 3 kg/m²) underwent metabolic studies, including measurement of insulin sensitivity by the insulin clamp technique. Patients then underwent either vertical banded gastroplasty with Roux-en-Y gastric bypass or biliopancreatic diversion and were restudied at 5–6 months and again at 16–24 months postsurgery. Results: At baseline, patients were hyperinsulinemic (194 ± 47 pmol/L vs 55 ± 25 pmol/L, p < .0001), hypertriglyceridemic (1.56 ± 0.30 mmol/L vs 0.78 ± 0.32 mmol/L, p < .0001), and profoundly insulin resistant (insulin-mediated glucose disposal: 20.8 ± 4.4μ mol/min/kg fat-free mass vs 52 ± 10.1 μmol/min/kg, p < .0001) as compared with controls. Weight loss by the 2 procedures was equivalent in both amount (averaging –53 kg) and time course. In the gastric bypass group, insulin sensitivity improved (23.8± 6 μmol/min/kg at 5 months and 33.7 ± 11.3 μmol/min/kg at 16 months, p < .01 vs baseline and controls). In contrast, in the biliopancreatic diversion group, insulin sensitivity was normalized already at 6 months (52.5 ± 12.4 μmol/min/kg, p = .72 vs controls) and increased further at 24 months (68.7 ± 9.5 μmol/min/kg, p < .01 vs controls), despite a persistent obese phenotype (body mass index 33.2 ± 8 kg/m²). Conclusions: In surgically treated obese patients, insulin sensitivity improves in proportion to weight loss with use of predominantly restrictive procedures (gastric bypass) but is reversed completely by predominantly malabsorptive approaches (biliopancreatic diversion) long before normalization of body weight. Selective nutrient absorption and gut hormones may interact with one another in the genesis of the metabolic abnormalities of obesity.

Get full access to this article

View all access options for this article.

References

Department of Health and Human Services, Centers for Disease Control and Prevention. CDC's national leadership role in addressing obesity. Available at: http://www.cdc.gov/doc.do/id/0900f3ec803207fd. Accessed October 25, 2005.

Steinbrook R. Surgery for severe obesity. N Engl J Med. 2004;350:1075– 1079.

Flancbaum L. Mechanisms of weight loss after surgery for clinically severe obesity. Obes Surg. 1999 ;9:516– 523.

Muscelli E, Mingrone G, Camastra S, et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med. 2005 ;118:51– 57.